Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens.
- 28 March 1995
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 92 (7), 2780-2784
- https://doi.org/10.1073/pnas.92.7.2780
Abstract
Aldose reductase (AR) has been implicated in the etiology of diabetic cataract, as well as in other complications. However, the role of AR in these complications remains controversial because the strongest supporting evidence is drawn from the use of AR inhibitors for which specificity in vivo cannot be ascertained. To settle this issue we developed transgenic mice that overexpress AR in their lens epithelial cells and found that they become susceptible to the development of diabetic and galactose cataracts. When the sorbitol dehydrogenase-deficient mutation is also present in these transgenic mice, greater accumulation of sorbitol and further acceleration of diabetic cataract develop. These genetic studies demonstrated convincingly that accumulation of polyols from the reduction of hexose by AR leads to the formation of sugar cataracts.Keywords
This publication has 29 references indexed in Scilit:
- An Unlikely Sugar Substrate Site in the 1.65 Å Structure of the Human Aldose Reductase Holoenzyme Implicated in Diabetic ComplicationsScience, 1992
- Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 monthsJournal of Diabetes and its Complications, 1992
- Identification of Fructose 3-Phosphate in the Lens of Diabetic RatsScience, 1990
- Regulation of the murine αA-crystallin promoter in transgenic miceDevelopmental Biology, 1990
- Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic ratsMetabolism, 1987
- The Pharmacology of Aldose Reductase InhibitorsAnnual Review of Pharmacology and Toxicology, 1985
- N-[[5-(Trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]-N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitorJournal of Medicinal Chemistry, 1984
- Sorbitol dehydrogenase genetics in the mouse: A ‘;null’ mutant in a ‘;European’ C57BL strainAnimal Blood Groups and Biochemical Genetics, 1982
- Polyol Accumulation in Galactosemic and Diabetic Rats: Control by an Aldose Reductase InhibitorScience, 1973
- Le mécanisme de la formation du fructose séminal et du fructose foetalBiochimica et Biophysica Acta, 1959